Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women/Experiment 6

From BugSigDB


Needs review

Curated date: 2024/11/19

Curator: Rahila

Revision editor(s): Rahila

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Breast cancer breast cancer,breast tumor,cancer of breast,malignant breast neoplasm,malignant breast tumor,malignant neoplasm of breast,malignant neoplasm of the breast,malignant tumor of breast,malignant tumor of the breast,mammary cancer,mammary neoplasm,mammary tumor,primary breast cancer,Breast cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Ductal carcinoma in situ (DCIS)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Breast cancer (BC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women with early-stage of breast cancer (BC),
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
47

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3.0

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2024/11/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 2 (C)

Description: Identification of microbial taxa that differentiate BC and DCIS groups of oral microbiota using LEfSe discriminant analysis.

Abundance in Group 1: increased abundance in Breast cancer (BC)

NCBI Quality ControlLinks
Phascolarctobacterium
Megamonas

Revision editor(s): Rahila

Signature 2

Needs review

Curated date: 2024/11/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 2 (B)

Description: Identification of microbial taxa that differentiate BC and DCIS groups of oral microbiota using LEfSe discriminant analysis.

Abundance in Group 1: decreased abundance in Breast cancer (BC)

NCBI Quality ControlLinks
Epsilonproteobacteria
Campylobacterales
Campylobacteraceae
Campylobacter

Revision editor(s): Rahila